Trader: Low Volume ...
Health Care: Drugs
Arena Pharmaceuticals Inc. (ARNA: NASDAQ)
$6.43 0.03 | 0.47%
06/04/12 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 6.40 |
| 52 Week High | 7.02 |
| 52 Week Low | 1.23 |
| Avg. Daily Vol. (Mil) | 14.76 |
| Beta (3 year) | -0.58 |
| Share Related Items | |
| Mkt Cap (Mil) | 1,261.76 |
| Shares Out (Mil) | 197.15 |
| Float (Mil) | 179.32 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 7.30 |
| Current Ratio | 7.50 |
| LT Debt/ Equity | 1.92 |
| Total Debt / Equity | 1.96 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 114.88 |
| Price/Book | 28.15 |
| Price/Cash Flow | -14.90 |
| Per Share Data | |
| Earnings | -0.66 |
| Sales | 0.06 |
| Book Value | 0.23 |
| Cash Flow | -0.43 |
| Business Summary | |
|---|---|
| Arena Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company committed to discovering and developing innovative therapies offering medical advances and new options for patients. | |
| General Information | |
| 6166 Nancy Ridge Drive
San Diego, CA 92121 |
|
| www.arenapharm.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 266 | |
| CEO: Jack Lief | |
| Short Interest | |
| Current Month (Mil) | 41.21 |
| Previous Month (Mil) | 44.60 |
| Short Interest Ratio (Days) | 2.10 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -51.10 |
| Return on Investments | -73.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with ARNA
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- Userchrisnash69 Portfolio 1
- User1st Time out
- Userbio
- UserWIDELY HELD IN GAME
- Usermarket watch 2012
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- UserHoldings
- ContributorStocks Under-$10 Moving Hig...
Latest ARNA Headlines from TheStreet
- Stocks Under $10: Why I'm a Buyer
05.31.12 | 07:05 am - 4 Stocks Under $10 Making Big Moves 05.30.12 | 03:05 pm
- Arena Pharmaceuticals Inc. (ARNA): Today's Featured Health Care Loser 05.25.12 | 05:05 pm
- Biotech Stock Mailbag: ASCO, Celldex, Obesity Drug Game-Changer 05.25.12 | 05:05 am
- Outlooks for Pfizer, Arena and Onyx Following Busy May 05.21.12 | 07:05 am
- Biotech Stock Live Chat Recap: ASCO & Obesity 05.17.12 | 11:05 am
- Stocks Under $10: Healthcare Name on Sale 05.17.12 | 07:05 am
- Hot Biotech Stocks Traded by Hedge Funds in First Quarter 05.16.12 | 07:05 am
- Arena Pharmaceuticals Inc. (ARNA): Today's Featured Health Care Winner 05.14.12 | 04:05 pm
- Mulling Arena Pharma's Future With Obesity Drug on Approval Path 05.14.12 | 03:05 pm
Press Releases for ARNA
- Arena Pharmaceuticals Investigated By Goldfarb Branham Law Firm LLP - Business Wire 10.08.10 | 09:10 am
- Girard Gibbs LLP Files Class Action Lawsuit Against Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) - Business Wire 09.29.10 | 05:09 pm
- Lieff Cabraser Heimann & Bernstein, LLP Announces Class Action Lawsuits Against Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) - Business Wire 09.28.10 | 02:09 pm
- Investor Notice: The Rosen Law Firm Announces Filing Of Securities Class Action Against Arena Pharmaceuticals, Inc. - ARNA - Business Wire 09.22.10 | 06:09 pm
- Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Arena Pharmaceuticals, Inc. - Business Wire 09.22.10 | 05:09 pm
- The Law Office Of Robbins Umeda LLP Announces An Investigation Of Arena Pharmaceuticals, Inc. - Business Wire 09.22.10 | 12:09 pm
Partner Headlines for ARNA
- Vivus' Qnexa Is Not Guaranteed Approval. Remember Provenge? - Benzinga 05.31.12 | 12:05 pm
- 4 Smaller Alternatives to Big Pharma Obesity Treatments - Benzinga 05.25.12 | 01:05 pm
- Pre-Market Most Active for May 22, 2012 : QQQ, NOK, FB, BBY, TEF, BAC, SNY, NVO, VOD, AAPL, ARNA, ZNGA - NASDAQ 05.22.12 | 12:05 pm
- Pre-Market Most Active for May 17, 2012 : SNY, BAC, BUD, MT, MTL, WMT, QQQ, VOD, AAPL, DNDN, ZNGA, ARNA - NASDAQ 05.17.12 | 12:05 pm
- Pre-Market Most Active for May 16, 2012 : CTL, SNY, BAC, GE, NCT, MT, QQQ, ARNA, SINA, PETD, ZNGA, RIMM - NASDAQ 05.16.12 | 12:05 pm
- After Hours Most Active for May 15, 2012 : DFG, TPX, JCP, GSM, QQQ, BAC, ARNA, CCJ, AIG, VELT, INTC, NWSA - NASDAQ 05.15.12 | 08:05 pm
- Pre-Market Most Active for May 14, 2012 : BAC, CHK, NOK, BBVA, CS, SIRI, JPM, ARNA, QQQ, YHOO, AAPL, FRAN - NASDAQ 05.14.12 | 12:05 pm
- Arena Pharmaceuticals: FDA Approval Is Just The Beginning - Seeking Alpha 05.13.12 | 09:05 am
- Benzinga's Top Upgrades with Color for May 11, 2012 - Benzinga 05.11.12 | 12:05 pm
- Social Media Outlook for Wednesday May 9 (PDC, DIS, STEC, FOSL) - Benzinga 05.09.12 | 01:05 pm
